PedAM
Pediatric Disease Annotations & Medicines
| Disease | pancreatitis |
| Phenotype | C0017178|gastrointestinal diseases |
| Sentences | 6 |
| PubMedID- 21076576 | Subjects were excluded from the study if they had a history of cardiovascular disease including peripheral atherosclerosis, chronic gastrointestinal diseases associated with malabsorption, chronic pancreatitis, history of any malignant disease, history of alcohol or drug abuse, liver or kidney failure, and treatments able to modify glucose metabolism, such as steroid. |
| PubMedID- 21911775 | Other exclusion criteria were history or clinical evidence of coronary or valvular heart disease, congestive heart failure, hyperlipidemia, peripheral vascular disease, chronic gastrointestinal diseases associated with malabsorption, chronic pancreatitis, history of any malignant disease, history of alcohol or drug abuse, liver or kidney failure, and treatments able to modify glucose metabolism. |
| PubMedID- 23326550 | Subjects were excluded if they had history of cardiovascular disease including peripheral atherosclerosis, chronic gastrointestinal diseases associated with malabsorption, chronic pancreatitis, history of any malignant disease, history of alcohol or drug abuse, positivity for antibodies to hepatitis c virus (hcv) or hepatitis b surface antigen (hbsag), and liver or kidney failure. |
| PubMedID- 23203035 | Subjects were excluded if they had a history of arterial hypertension, other exclusionary criteria were chronic gastrointestinal diseases associated with malabsorption, chronic pancreatitis, history of any malignant disease, history of alcohol or drug abuse, liver or kidney failure, and treatments able to modify glucose metabolism. |
| PubMedID- 22164268 | Subjects, aged 23–70 years, were excluded if they had history of cardiovascular disease, including peripheral atherosclerosis, chronic gastrointestinal diseases associated with malabsorption, chronic pancreatitis, history of any malignant disease, history of alcohol or drug abuse, liver or kidney failure, or received treatments able to modify glucose metabolism including glucose-lowering, lipid-lowering and antihypertensive therapy. |
| PubMedID- 23028545 | Other exclusion criteria were history or clinical evidence of coronary and valvular heart disease, congestive heart failure, hyperlipidemia, peripheral vascular disease, chronic gastrointestinal diseases associated with malabsorption, chronic pancreatitis, history of any malignant disease, history of alcohol or drug abuse, liver or kidney failure and treatments able to modify glucose metabolism. |
Page: 1